BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 291506)

  • 1. [Pseudo-hyperkalaemia in myeloproliferative diseases (author's transl)].
    Fink M; Hiller E; Huhn D; Brunswicker F
    Dtsch Med Wochenschr; 1979 Nov; 104(46):1639-41. PubMed ID: 291506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudohyperkalaemia is a common finding in myeloproliferative disorders that may lead to inappropriate management of patients.
    Ong YL; Deore R; El-Agnaf M
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e151-7. PubMed ID: 19016918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Must we always treat hyperkalaemia?].
    Basile C; Manobianca G; Bruno A; Tamma F
    G Ital Nefrol; 2013; 30(1):. PubMed ID: 23832444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pseudohyperkalemia in the serum in reactive thrombocytosis and thrombocythemia].
    Mödder B; Meuthen I
    Dtsch Med Wochenschr; 1986 Feb; 111(9):329-32. PubMed ID: 3948731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudohyperkalaemia - a cause of diagnostic confusion.
    Parker NE; Jacobs P
    S Afr Med J; 1981 Dec; 60(25):973-4. PubMed ID: 7330742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.
    Ryningen A; Apelseth T; Hausken T; Bruserud Ø
    Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markedly increased small-sized megakaryocytes and platelets count in the circulation with pseudo-hyperkalemia following splenectomy.
    Li G; Wang B; Li D; Zhu R; Chen X
    Eur J Med Res; 2022 Aug; 27(1):155. PubMed ID: 35999645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical Grand Rounds--chronic granulocytic leukemia with thrombocytosis; the hypercoagulability states.
    Kossmann CE; Hubbard WS; Chesney CM
    J Tenn Med Assoc; 1981 Oct; 74(10):742-3, 745. PubMed ID: 6947124
    [No Abstract]   [Full Text] [Related]  

  • 9. [Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
    Meschengieser SS; Woods AI; Schattner MA; Lazzari MA
    Medicina (B Aires); 1981; 41 Suppl():267-73. PubMed ID: 6954340
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypokalaemia and subsequent hyperkalaemia in hospitalized patients.
    Crop MJ; Hoorn EJ; Lindemans J; Zietse R
    Nephrol Dial Transplant; 2007 Dec; 22(12):3471-7. PubMed ID: 17848395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenetic mechanism of the changing cell picture in myeloproliferative syndromes (author's transl)].
    Bakalos D; Pararas M; Pathouli C; Tsikrikas T
    MMW Munch Med Wochenschr; 1974 Feb; 116(8):369-72. PubMed ID: 4208094
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches.
    Ngugi NN; McLigeyo SO; Kayima JK
    East Afr Med J; 1997 Aug; 74(8):503-9. PubMed ID: 9487416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meningeal leukemia during blast crisis in a chronic myeloproliferative syndrome].
    Gabryś K; Kuliczkowski K
    Wiad Lek; 1981 Feb; 34(3):245-9. PubMed ID: 6942592
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertension and hyperkalaemia responding to bendrofluazide.
    Lee MR; Ball SG; Thomas TH; Morgan DB
    Q J Med; 1979 Apr; 48(190):245-58. PubMed ID: 504550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet membrane fatty acids in thrombocytosis due to myeloproliferative disorders.
    Leoncini G; Maresca M; Balestrero F; Benatti U; Armani U; Piana A
    Cell Biochem Funct; 1984 Jan; 2(1):23-5. PubMed ID: 6467512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombocytosis and hyperkalemia revisited.
    Fort JA
    Am J Pediatr Hematol Oncol; 1989; 11(3):334-6. PubMed ID: 2782564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
    Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
    Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Report on familial paroxysmal hypokalaemic paralysis in relation to postoperative intensive care (author's transl)].
    Feurstein V
    Anaesthesist; 1980 Nov; 29(11):632-4. PubMed ID: 7457804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Irradiation of the spleen during malign diseases of the blood (author's transl)].
    Ermanni M; Straub PW
    Strahlentherapie; 1977 Jan; 153(1):1-8. PubMed ID: 264711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experiences with the treatment of acute leukemias and blast crises in chronic myeloproliferative diseases].
    Eggeling T; Braumann D; Mainzer K
    Med Welt; 1981 Jul; 32(27):1077-80. PubMed ID: 6943405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.